IBD disease-modifying therapies: insights from emerging therapeutics
Inflammatory bowel disease (IBD) pathogenesis is associated with gut mucosal
inflammation, epithelial damage, and dysbiosis leading to a dysregulated gut mucosal …
inflammation, epithelial damage, and dysbiosis leading to a dysregulated gut mucosal …
Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease
D Li, M Yang, H Xu, M Zhu, Y Zhang, C Tian… - Journal of Materials …, 2022 - pubs.rsc.org
As a group of chronic and idiopathic gastrointestinal (GI) disorders, inflammatory bowel
disease (IBD) is characterized by recurrent intestinal mucosal inflammation. Oral …
disease (IBD) is characterized by recurrent intestinal mucosal inflammation. Oral …
Hyaluronic acid‐based Bioconjugate systems, Scaffolds, and their therapeutic potential
In recent years, the development of hyaluronic acid or hyaluronan (HA) based scaffolds,
medical devices, bioconjugate systems have expanded into a broad range of research and …
medical devices, bioconjugate systems have expanded into a broad range of research and …
[HTML][HTML] Recent advances and prospects of hyaluronan as a multifunctional therapeutic system
Hyaluronan (HA) is a naturally occurring non-sulfated glycosaminoglycan (GAG), cell-
surface-associated biopolymer and is the key component of tissue extracellular matrix …
surface-associated biopolymer and is the key component of tissue extracellular matrix …
Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems
H Hadji, K Bouchemal - Advanced Drug Delivery Reviews, 2022 - Elsevier
The complex pathogenesis of inflammatory bowel disease (IBD) explains the several
hurdles for finding an efficient approach to cure it. Nowadays, therapeutic protocols aim to …
hurdles for finding an efficient approach to cure it. Nowadays, therapeutic protocols aim to …
[HTML][HTML] Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease
Delivering drugs directly to the inflamed intestinal sites to treat inflammatory bowel disease
(IBD), particularly Crohn's and ulcerative colitis, is highly challenging. Recent advances in …
(IBD), particularly Crohn's and ulcerative colitis, is highly challenging. Recent advances in …
Modulation of gut barrier functions in ulcerative colitis by hyaluronic acid system
The active stages of intestinal inflammation and the pathogenesis of ulcerative colitis are
associated with superficial mucosal damage and intermittent wounding that leads to …
associated with superficial mucosal damage and intermittent wounding that leads to …
[HTML][HTML] Novel drug delivery systems for inflammatory bowel disease
Inflammatory bowel disease (IBD) is a chronic illness characterized by relapsing
inflammation of the intestines. The disorder is stratified according to the severity and is …
inflammation of the intestines. The disorder is stratified according to the severity and is …
Natural product-based nanomedicine in treatment of inflammatory bowel disease
Many synthetic drugs and monoclonal antibodies are currently in use to treat Inflammatory
Bowel Disease (IBD). However, they all are implicated in causing severe side effects and …
Bowel Disease (IBD). However, they all are implicated in causing severe side effects and …
Colon-targeted delivery systems for nutraceuticals: A review of current vehicles, evaluation methods and future prospects
K Feng, Y Wei, T Hu, RJ Linhardt, M Zong… - Trends in Food Science & …, 2020 - Elsevier
Background Advances in nutriology have suggested the colon as a superior site for nutrition
absorption. Nutraceuticals, including phytochemicals, probiotics, etc., have received great …
absorption. Nutraceuticals, including phytochemicals, probiotics, etc., have received great …